Dec 20 (Reuters) - Benitec Biopharma Ltd BLT.AX :
* Benitec Biopharma - "significant" progress on use of co's technology for development of a ddRNAi based therapeutic for treatment of hepatitis b virus
* Benitec Biopharma Ltd - anticipate meeting with a number of regulatory agencies in early 2017 for the ddRNAi treatment study Source text for Eikon: ID:nPn42XHFZa Further company coverage: BLT.AX